INPP5A
Basic information
Region (hg38): 10:132537787-132783480
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the INPP5A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 22 | 22 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 22 | 1 | 2 |
Variants in INPP5A
This is a list of pathogenic ClinVar variants found in the INPP5A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-132538116-C-T | not specified | Uncertain significance (Jun 10, 2024) | ||
10-132538118-C-T | not specified | Uncertain significance (Dec 22, 2023) | ||
10-132538121-G-A | not specified | Uncertain significance (Jun 21, 2023) | ||
10-132538125-C-T | not specified | Uncertain significance (Apr 22, 2022) | ||
10-132538130-G-T | not specified | Uncertain significance (Aug 21, 2023) | ||
10-132607943-G-A | not specified | Uncertain significance (Aug 08, 2022) | ||
10-132645871-G-A | not specified | Uncertain significance (Dec 07, 2021) | ||
10-132645908-G-C | not specified | Uncertain significance (May 03, 2023) | ||
10-132645933-C-T | Likely benign (Apr 03, 2018) | |||
10-132645956-A-G | not specified | Uncertain significance (Dec 16, 2022) | ||
10-132650446-G-A | not specified | Uncertain significance (Dec 27, 2023) | ||
10-132697858-A-G | not specified | Uncertain significance (Sep 22, 2022) | ||
10-132697865-A-C | not specified | Uncertain significance (Mar 20, 2024) | ||
10-132726835-G-A | not specified | Uncertain significance (Nov 13, 2023) | ||
10-132726884-G-A | Benign (Jun 10, 2018) | |||
10-132749539-T-C | not specified | Uncertain significance (Mar 01, 2023) | ||
10-132749566-A-G | not specified | Uncertain significance (Jul 10, 2023) | ||
10-132749583-A-G | not specified | Uncertain significance (Aug 30, 2022) | ||
10-132749597-G-A | Benign (Dec 31, 2019) | |||
10-132749608-G-A | not specified | Uncertain significance (Mar 25, 2024) | ||
10-132749771-G-A | not specified | Uncertain significance (Jun 07, 2023) | ||
10-132749801-G-C | not specified | Uncertain significance (Feb 06, 2023) | ||
10-132765789-A-G | not specified | Uncertain significance (Sep 20, 2023) | ||
10-132777693-C-T | not specified | Uncertain significance (Mar 29, 2023) | ||
10-132777774-G-C | not specified | Uncertain significance (Jul 19, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
INPP5A | protein_coding | protein_coding | ENST00000368594 | 15 | 245656 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.981 | 0.0188 | 125742 | 0 | 6 | 125748 | 0.0000239 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.78 | 176 | 256 | 0.687 | 0.0000166 | 2739 |
Missense in Polyphen | 42 | 82.86 | 0.50688 | 828 | ||
Synonymous | -0.781 | 112 | 102 | 1.10 | 0.00000730 | 721 |
Loss of Function | 4.38 | 4 | 29.8 | 0.134 | 0.00000160 | 334 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000353 | 0.0000352 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000654 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Major isoenzyme hydrolyzing the calcium-mobilizing second messenger Ins(1,4,5)P3, this is a signal-terminating reaction.;
- Pathway
- Inositol phosphate metabolism - Homo sapiens (human);Phosphatidylinositol signaling system - Homo sapiens (human);D-<i>myo</i>-inositol (1,3,4)-trisphosphate biosynthesis;superpathway of D-<i>myo</i>-inositol (1,4,5)-trisphosphate metabolism;1D-<i>myo</i>-inositol hexakisphosphate biosynthesis II (mammalian);Inositol phosphate metabolism;D-<i>myo</i>-inositol (1,4,5)-trisphosphate degradation;Metabolism;superpathway of inositol phosphate compounds;Inositol phosphate metabolism;Synthesis of IP2, IP, and Ins in the cytosol
(Consensus)
Recessive Scores
- pRec
- 0.205
Intolerance Scores
- loftool
- 0.178
- rvis_EVS
- -0.42
- rvis_percentile_EVS
- 25.64
Haploinsufficiency Scores
- pHI
- 0.115
- hipred
- Y
- hipred_score
- 0.761
- ghis
- 0.551
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.989
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Inpp5a
- Phenotype
- homeostasis/metabolism phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- inositol phosphate metabolic process;inositol phosphate dephosphorylation;phosphatidylinositol dephosphorylation;inositol phosphate-mediated signaling
- Cellular component
- plasma membrane;membrane
- Molecular function
- inositol-polyphosphate 5-phosphatase activity;protein binding;PH domain binding;inositol-1,4,5-trisphosphate 5-phosphatase activity;inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity